首页> 美国卫生研究院文献>HPB : The Official Journal of the International Hepato Pancreato Biliary Association >Use of a collagen-sealing device in hepatic resection: a comparative analysis to standard resection technique
【2h】

Use of a collagen-sealing device in hepatic resection: a comparative analysis to standard resection technique

机译:在肝切除术中使用胶原蛋白密封装置:与标准切除术技术的对比分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Blood transfusion has been reported as an independent risk factor for poor outcome after liver resection in spite of its well known benefits. Refinements in parenchymal dissection have been pursued to reduce blood loss and transfusion. A collagen-sealing device (CSD) has recently been touted as an alternative technique that aids in blood conservation. We report the results of our initial series of patients undergoing a CSD-assisted resection and present a historical comparison. Patients and methods. Consecutive patients who were undergoing liver resection at a single tertiary cancer centre were enrolled in this study. The Ligasure Atlas device (Valleylab Inc., Division of Tyco Healthcare) was used for parenchymal division in the CSD group. Known blood conservation techniques (i.e. low central venous pressure, ultrasonic dissection, Pringle clamp) were standardized in both groups. Clinical and outcome variables including operative time, estimated blood loss and transfusion requirements were collected. All statistical analyses were performed with SAS version 8.2e. Results. In all, 28 consecutive patients underwent CSD-assisted hepatic resection between October 2003 and September 2004. The control group included 188 patients treated between January 1991 and September 2003. In the CSD group, we observed a reduction in mean estimated blood loss (930 vs 1450 ml, p=0.002) and mean transfusion requirements (0.46 vs 1.19 units, p=0.002). There was no increase in operative time with the new instrument (326 vs 363 min, p=0.167). Discussion. Use of a CSD has the potential to further reduce blood loss and transfusion requirements without increasing operative time.
机译:背景。尽管有众所周知的好处,但有报道称输血是肝脏切除术后预后不良的独立危险因素。为了减少失血和输血,一直在进行实质性解剖的改良。近年来,胶原蛋白密封装置(CSD)被吹捧为有助于血液保存的替代技术。我们报告了接受CSD辅助切除术的首批患者的结果,并进行了历史比较。患者和方法。在一个三级癌症中心接受肝切除的连续患者参加了这项研究。 Ligasure Atlas设备(Tyco Healthcare部门Valleylab Inc.)用于CSD组的实质分裂。两组均采用已知的血液保存技术(即低中心静脉压,超声解剖,普林格钳)。收集包括手术时间,估计失血量和输血需求在内的临床和预后变量。所有统计分析均使用SAS版本8.2e进行。结果。在2003年10月至2004年9月之间,共有28例患者接受了CSD辅助肝切除术。对照组包括1991年1月至2003年9月之间接受治疗的188例患者。在CSD组中,我们观察到平均估计失血量减少了(930 vs 1450 ml,p = 0.002)和平均输血量(0.46 vs 1.19单位,p = 0.002)。新仪器的手术时间没有增加(326 vs 363 min,p = 0.167)。讨论。使用CSD有可能在不增加手术时间的情况下进一步减少失血量和输血量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号